Join
Live feed
·
INSIDERFilingvia Quantisnow
Turn Therapeutics Inc. logo

Director Kester Kent Edward was granted 10,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TTRX· Turn Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTRX (Turn Therapeutics Inc.) and more on Quantisnow.

Director Kester Kent Edward was granted 10,000 shares (SEC Form 4) | Quantisnow